Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Personal Products Industry Analysis

UpdatedMay 26, 2026
DataAggregated Company Financials
Companies107
  • 7D5.0%
  • 3M-17.8%
  • 1Y-15.2%
  • YTD-11.3%

In the last week, the Personal Products industry is up 5.0%, with Estée Lauder Companies up 16%. In the past year, the industry is down 15%. As for the next few years, earnings are expected to grow by 34% per annum.

Industry Valuation and Performance

Has the U.S. Personal Products Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 26 May 2026US$80.8bUS$48.4bUS$753.3m15.7x107.2x1.7x
Thu, 23 Apr 2026US$77.7bUS$48.1bUS$614.6m22.6x126.4x1.6x
Sat, 21 Mar 2026US$80.8bUS$48.2bUS$678.5m21.5x119.1x1.7x
Mon, 16 Feb 2026US$93.8bUS$48.0bUS$846.8m22.5x110.8x2x
Wed, 14 Jan 2026US$92.9bUS$47.6bUS$350.3m21.7x265.2x2x
Fri, 12 Dec 2025US$91.3bUS$47.6bUS$351.2m23.2x260x1.9x
Sun, 09 Nov 2025US$83.1bUS$47.5bUS$491.5m20.6x169.1x1.8x
Tue, 07 Oct 2025US$88.1bUS$47.7bUS$307.3m20.1x286.6x1.8x
Thu, 04 Sep 2025US$100.6bUS$47.6bUS$303.6m22.1x331.4x2.1x
Sat, 02 Aug 2025US$101.6bUS$48.1bUS$113.1m20.7x897.5x2.1x
Mon, 30 Jun 2025US$96.7bUS$48.0bUS$109.4m17.5x883.9x2x
Wed, 28 May 2025US$93.8bUS$48.0bUS$113.4m18.4x827.5x2x
Fri, 25 Apr 2025US$85.3bUS$48.7bUS$549.4m21.7x155.2x1.8x
Sun, 23 Mar 2025US$91.0bUS$48.7bUS$378.1m28.1x240.7x1.9x
Tue, 18 Feb 2025US$90.8bUS$49.0bUS$335.7m23.9x270.4x1.9x
Thu, 16 Jan 2025US$95.8bUS$49.3bUS$1.5b26.3x64.9x1.9x
Sat, 14 Dec 2024US$103.6bUS$49.3bUS$1.5b29.1x70.1x2.1x
Mon, 11 Nov 2024US$98.2bUS$49.3bUS$1.5b27.3x66.8x2x
Wed, 09 Oct 2024US$107.5bUS$49.5bUS$1.6b25.9x66.5x2.2x
Fri, 06 Sep 2024US$110.0bUS$49.5bUS$1.6b21x67.2x2.2x
Sun, 04 Aug 2024US$105.2bUS$48.9bUS$2.5b22.9x42.6x2.2x
Tue, 02 Jul 2024US$111.3bUS$49.0bUS$2.4b21.3x45.9x2.3x
Thu, 30 May 2024US$118.1bUS$49.0bUS$2.4b20.3x48.7x2.4x
Sat, 27 Apr 2024US$125.7bUS$48.8bUS$2.5b24.6x49.5x2.6x
Mon, 25 Mar 2024US$130.8bUS$48.8bUS$2.5b24.6x52.5x2.7x
Wed, 21 Feb 2024US$127.1bUS$49.2bUS$2.5b30.1x50.7x2.6x
Fri, 19 Jan 2024US$123.0bUS$50.1bUS$2.6b27.1x48.2x2.5x
Sun, 17 Dec 2023US$127.2bUS$49.9bUS$2.6b27.1x48.3x2.5x
Tue, 14 Nov 2023US$105.8bUS$49.9bUS$2.7b23.8x39.4x2.1x
Thu, 12 Oct 2023US$118.0bUS$50.0bUS$3.3b24.3x36x2.4x
Sat, 09 Sep 2023US$129.9bUS$50.0bUS$3.3b19.8x39.6x2.6x
Mon, 07 Aug 2023US$142.8bUS$49.9bUS$3.1b25.9x46x2.9x
Wed, 05 Jul 2023US$154.4bUS$49.3bUS$3.1b22.7x49.2x3.1x
Fri, 02 Jun 2023US$144.3bUS$49.0bUS$3.3b21.6x43.3x2.9x
Price to Earnings Ratio

43.3x


Total Market Cap: US$144.3bTotal Earnings: US$3.3bTotal Revenue: US$49.0bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Personal Products Industry Price to Earnings3Y Average 170.6x202420252026
Current Industry PE
  • Investors are pessimistic on the American Personal Products industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 107x which is lower than its 3-year average PE of 171x.
  • The 3-year average PS ratio of 2.2x is higher than the industry's current PS ratio of 1.7x.
Past Earnings Growth
  • The earnings for companies in the Personal Products industry have declined 39% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Consumer Staples industry?

US Market1.21%
Consumer Staples-3.30%
Personal Products5.00%
Personal Products5.00%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EL Estée Lauder CompaniesUS$88.3216.0%
+US$4.4b		31.7%PS2.2x
KVUE KenvueUS$17.532.2%
+US$729.6m		-26.7%PE20.8x
IPAR InterparfumsUS$92.637.1%
+US$196.6m		-30.5%PE17.5x
EPC Edgewell Personal CareUS$17.669.4%
+US$70.0m		-35.5%PS0.4x
HLF HerbalifeUS$12.432.2%
+US$28.0m		62.7%PE5.4x

Latest News

EL
US$88.32
Estée Lauder Companies
7D
10.4%
1Y
38.7%
ELF
US$52.90
e.l.f. Beauty
7D
-3.6%
1Y
-37.0%
NATR
US$21.85
Nature's Sunshine Products
7D
-1.8%
1Y
53.1%
Narrative Update • May 24

NATR: Underpenetrated Digital And Regional Channels Will Support Future Upside Potential

Narrative Update: Nature's Sunshine Products The analyst price target for Nature's Sunshine Products has been raised from $33 to $35. Analysts cite recent Q4 beats, ongoing upward estimate revisions, and indications that the portfolio remains under-penetrated across key markets and digital channels.
BRBR
US$8.91
BellRing Brands
7D
-3.8%
1Y
-85.6%
HLF
US$12.43
Herbalife
7D
-1.3%
1Y
86.6%
EPC
US$17.66
Edgewell Personal Care
7D
9.4%
1Y
-35.5%
Narrative Update • May 23

EPC: Share Repurchases And Margin Reset Will Support Future Upside Potential

Analysts have kept their $21.00 price target for Edgewell Personal Care unchanged, citing updated assumptions that include a slightly higher discount rate, a smaller expected revenue decline, a higher projected profit margin, and a lower future P/E multiple as key factors behind the maintained valuation view. What's in the News Updated full fiscal year 2026 outlook now calls for reported net sales to be in a range of approximately 0.8% to 3.8%, compared with the prior range of 0.5% to 3.5%.
COTY
US$2.03
Coty
7D
1.0%
1Y
-57.5%
KVUE
US$17.53
Kenvue
7D
2.0%
1Y
-26.1%
WALD
US$1.30
Waldencast
7D
-16.7%
1Y
-45.1%
BNKK
US$1.87
Bonk
7D
-13.8%
1Y
-86.9%
FTLF
US$10.07
FitLife Brands
7D
-6.9%
1Y
-30.9%
NAGE
US$3.66
Niagen Bioscience
7D
-1.1%
1Y
-63.0%
Narrative Update • May 14

NAGE: Core Demand And Injectables Will Drive Future Upside Potential

Niagen Bioscience's analyst price target has shifted from $13.60 to $12.60, as analysts adjust their models to slightly lower revenue growth, profit margin, and fair value assumptions while still highlighting ongoing demand in the core business and potential upside from the injectable segment. Analyst Commentary Recent research updates show a consistent pattern of price target reductions, with the latest move taking the blended target to US$12.60.
HNST
US$3.41
Honest Company
7D
4.3%
1Y
-29.7%
OLPX
US$2.05
Olaplex Holdings
7D
1.0%
1Y
72.3%
USNA
US$18.74
USANA Health Sciences
7D
3.9%
1Y
-36.3%
IPAR
US$92.63
Interparfums
7D
6.0%
1Y
-28.7%